CG
NOVT icon

Cynosure Group’s Novanta NOVT Stock Holding History

Cynosure Group’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,524
Closed -$353K – 487
2025
Q3 		$353K Hold
3,524
– – 0.04% 321
2025
Q2 		$454K Buy
3,524
+1,099
+45% +$134K 0.05% 202
2025
Q1 		$310K Buy
2,425
+456
+23% +$65.6K 0.04% 346
2024
Q4 		$301K Sell
1,969
-297
-13% -$50.3K 0.04% 237
2024
Q3 		$405K Sell
2,266
-17
-0.7% -$2.96K 0.06% 201
2024
Q2 		$372K Buy
2,283
+546
+31% +$88.6K 0.06% 280
2024
Q1 		$304K Buy
+1,737
New +$285K 0.05% 297

Other funds holding NOVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cynosure Group's NOVT Position: Q4 2025 in Review

Cynosure Group sold out of Novanta (NOVT) in Q4 2025, closing a stake of 3,524 shares — an estimated $353K sold.

Cynosure Group first reported a position in NOVT in Q1 2024 and held it in 7 quarters. The position peaked at $454K in Q2 2025. 328 funds tracked by Wall St. Rank hold NOVT as of Q4 2025.

  • Cynosure Group reported no remaining Novanta position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 3,524 Novanta shares in Q4 2025, an estimated $353K.
  • Cynosure Group first reported a position in Novanta in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's Novanta position peaked at $454K in Q2 2025.
  • 328 funds tracked by Wall St. Rank held Novanta as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.